Finland Seeks to Lead the Silver Economy Charge

As Nordic economy faces an ageing population, its businesses seek an opportunity

Europe is slowly and steadily getting older. Today there are 3.3 people of working age — 15 to 64 — for every one over 65; by 2070 it will be just 2, according to the European Commission.

The conventional way to look at this ageing is as a huge challenge to society, public services, and governments. An older population will put immense strain on everything from healthcare to pensions. There is little sign that Europe is well prepared.

However, there is another way of viewing the shifting demographics — as an untapped opportunity for businesses to reach a new breed of customer. There has been some talk of the so-called “silver economy” but there are finally small signs that the topic is being taken more seriously in boardrooms and cabinets.

There is little surprise that one of the countries taking it most seriously is Finland. The Nordic country of 5.5m people has the most rapidly-ageing population among large EU countries and was once only behind Japan globally. Its previous centre-right government collapsed in March due to its inability to pass a healthcare reform necessary to offset the impact of an ageing population.

Finland has been thinking for decades about the effect of having an increasing number of elderly citizens. But it is only recently that business has caught up. Esko Aho, who is both a former senior executive at Nokia and ex-Finnish prime minister, is one of the movers behind a new high-level forum on the silver economy to be held in Helsinki next month.

The forum — tied into Finland’s EU presidency that starts just days earlier — brings together business leaders such as senior executives from pharmaceuticals group Bayer, insurer Aegon, and furniture retailer Ikea with policymakers including the mayor of Manchester and the president of the Federal Reserve of Kansas City.

“If we don’t do anything it will stay a problem, not an opportunity,” said Mr Aho. “But if we are able to meet these challenges, there will not be much harm for society. Maybe the opposite — people will live longer and be happier.”

He espouses the catchphrase of many in this area: “silver is the next green”. The parallels with climate change may be inexact but some are striking.

The changes from ageing are perhaps not visible day to day but over several years they certainly are. As with the early days of renewable energy, there is a lack of both a market and investors with both needing the other. “It’s like sustainability — it’s not enough to change something in the field of climate change; you have to change mindsets and the fundamental set-up of the economic system,” said Mr Aho.

For business, the size of the market is apparent but seizing the opportunity is harder. A study from last year estimated the value of the silver economy in Europe — defined as the spending by the population aged over 50 on goods and services — is €3.7tn and is expected to grow to €5.7tn by 2025, according to a European Commission study.

Some companies are an obvious fit with an ageing population. Bayer, the German pharmaceuticals group, is sending both its chief executive Werner Baumann and chief medical officer Michael Devoy to Helsinki. “As we continue to see rapidly ageing populations around the world, effectively tackling and managing age-related illnesses have become pivotal. We have to focus on addressing these unmet needs,” said Mr Devoy.

But there is an opportunity for businesses not just to provide what older people need but also what they want. Technology and entertainment groups, financial services companies, home designers, travel businesses — all are not obviously connected to ageing but each one could adapt their products better to better serve older customers. Some start-ups are active in the area but few have shot to prominence yet. Experts believe entrepreneurs and venture capitalists need to take the silver economy more seriously.

Mr Aho’s aims for the first meeting are relatively modest — to start dialogue between companies and governments while bringing the opportunities arising from an ageing population to a global audience. But as much of Europe and Asia face rapidly ageing populations over this century the need for businesses to come up with their own strategy for dealing with it will grow and grow.

Source: Financial Times

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.